Author

H. Hellemans

Observed names: H Hellemans, Hedwig Hellemans

Institution: AZ Sint-Lucas

Observed institutions: University of Milan, Universitair Ziekenhuis Leuven, AZ Sint-Lucas, KU Leuven

OpenAlex ID: A5079200525

Ticlopidine in the treatment of intermittent claudication: a 21-month double-blind trial.

1989 · F Balsano, S Coccheri, et al. · PubMed · 116

Placebo-controlled, Double-blind, Two-centre Trial of Ketanserin in Intermittent Claudication

1985 · H. Bounameaux, H. Hellemans, et al. · The Lancet · 26

Ketanserin (5 HT2-Antagonist) in Secondary Raynaudʼs Phenomenon

1984 · Henri M. Bounameaux, Hedwig Hellemans, et al. · Journal of Cardiovascular Pharmacology · 20

Ketanserin in chronic sympathetic dystrophy. An acute controlled trial

1984 · H. M. Bounameaux, H. Hellemans, et al. · Clinical Rheumatology · 18

Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.

1986 · H M Bounameaux, H Hellemans, et al. · PubMed · 5

Anaplastic nodules in an ovarian mucinous tumor. Case report and literature review.

1998 · H Hellemans, P Moerman, et al. · PubMed · 3

000126: the Value of [18f] Fluorodeoxyglucose Positron Emission Tomography in Placental Site Trofo- Blast Tumor

2005 · A. Coosemans, P.H. Moerman, et al. · International Journal of Gynecological Cancer

Long term ticlopidine administration increases walking distance and ankle blood pressure in claudicants: a 2 year double blind study

1989 · A Libretti, M. Catalano, et al.

Enhancement in walking ability and ankle blood-pressure under ticlopidine in 2nd-stage peripheral arterial-disease (PAD) patients – a 21 month double-blind study

1989 · S Coccheri, F Balsano, et al.

Erfahrungen mit niedermolekularen Heparinfraktionen unter spezieller Berücksichtigung ihrer Wirkung auf die Thrombozytenfunktion

1986 · H Bounameaux, H Hellemans, et al.

Works count: 10

Citation count: 188

H-index: 5

I10-index: 4